CVM logo

Cel-Sci Corporation


CVM: CEL-SCI Corp is a player in the biotechnology sector. It is engaged in the research and development at developing the treatment of cancer and other diseases by using the immune system. The company is focused on activating the immune system to fight cancer and infectious diseases. It is focused on the development of Multikine (Leukocyte Interleukin, Injection), investigational immunotherapy under development for the treatment of certain head and neck cancers, and anal warts or cervical dysplasia.


Show CVM Financials

Consumer Interest
SEC Filings

Recent trades of CVM by members of U.S. Congress

Quiver Logo

No Congress Trading data for this ticker

Congress Trading Dashboard

Recently reported changes by institutional investors

Quarterly net insider trading by CVM's directors and management

Quiver Logo

No recent Insider Trading for this ticker

Insider Trading Dashboard

Government lobbying spending instances

  • $40,000 Dec 30, 2020 Issue: Medical/Disease Research/Clinical Labs
  • $50,000 Oct 18, 2020 Issue: Medical/Disease Research/Clinical Labs
  • $50,000 Jul 09, 2020 Issue: Medical/Disease Research/Clinical Labs
  • $50,000 Apr 13, 2020 Issue: Medical/Disease Research/Clinical Labs
U.S. Patents

New patents grants

Quiver Logo

No new patents for this ticker

U.S. Patents Dashboard
Government Contracts

Federal grants, loans, and purchases

Quiver Logo

No Government Contracts for this ticker

Government Contracts Dashboard

Number of mentions of CVM in WallStreetBets Daily Discussion

CVM News

Recent insights relating to CVM

CNBC Recommendations

Recent picks made for CVM stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in CVM

Corporate Flights

Flights by private jets registered to CVM